EC
Euclidean Capital’s RAPT Therapeutics RAPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $658K | Sell |
82,234
-575,665
| -88% | -$4.61M | 0.22% | 9 |
|
|
2025
Q1 | $803K | Hold |
657,899
| – | – | 0.3% | 9 |
|
|
2024
Q4 | $1.04M | Hold |
657,899
| – | – | 0.14% | 10 |
|
|
2024
Q3 | $1.32M | Hold |
657,899
| – | – | 0.15% | 10 |
|
|
2024
Q2 | $2.01M | Hold |
657,899
| – | – | 0.25% | 9 |
|
|
2024
Q1 | $5.91M | Hold |
657,899
| – | – | 0.76% | 7 |
|
|
2023
Q4 | $16.3M | Hold |
657,899
| – | – | 1.84% | 4 |
|
|
2023
Q3 | $10.9M | Buy |
657,899
+86,666
| +15% | +$1.44M | 2.39% | 5 |
|
|
2023
Q2 | $10.7M | Buy |
571,233
+138,333
| +32% | +$2.59M | 2.75% | 7 |
|
|
2023
Q1 | $7.94M | Hold |
432,900
| – | – | 6.97% | 4 |
|
|
2022
Q4 | $8.57M | Hold |
432,900
| – | – | 8.02% | 5 |
|
|
2022
Q3 | $10.4M | Hold |
432,900
| – | – | 9.67% | 4 |
|
|
2022
Q2 | $7.9M | Hold |
432,900
| – | – | 6.72% | 6 |
|
|
2022
Q1 | $9.52M | Hold |
432,900
| – | – | 5.53% | 7 |
|
|
2021
Q4 | $15.9M | Sell |
432,900
-202,277
| -32% | -$7.43M | 9.04% | 5 |
|
|
2021
Q3 | $19.7M | Sell |
635,177
-100,624
| -14% | -$3.12M | 9.59% | 3 |
|
|
2021
Q2 | $23.4M | Hold |
735,801
| – | – | 7.59% | 4 |
|
|
2021
Q1 | $16.3M | Hold |
735,801
| – | – | 5.47% | 7 |
|
|
2020
Q4 | $14.5M | Buy |
+735,801
| New | +$14.5M | 3.08% | 8 |
|